Find your path to Rob
628 people in our graph share verified history with Rob — schools, employers, funds. One of them is your warm intro.
Teresa ChanunlockedRob: together at Johnson & Johnson (2002–2004)
×3Rob: together at Dartmouth College
Rob: together at Harvard Medical School
×3Rob: together at Johnson & Johnson
Chief Medical Officer at Noema Pharma
Intro paths
→
In turn, Rob can intro founders to Noema Pharma's investors below.
Noema Pharma's investors · 9
BioMedPartnersBasel · $648K – $6.5M checksEQTNew York · since 2025EQT Life SciencesLuxembourg · $11M – $66M checks · since 2025ForbionNaarden · since 2025Gilde HealthcareUtrecht · $1.1M – $55M checks · since 2025InvusNew York · since 2025Jeito CapitalParis · since 2025Roche Venture FundBasel · $648K – $3.2M checksSofinnova PartnersParis · $540K – $27M checks · since 2025
Experience
- Noema PharmaChief Medical Officercurrent2023 — present
- Sage TherapeuticsVice President Clinical Development2018 — 2023Greater Boston Area
- Medday PharmaceuticalsChief Medical Officer2017 — 2018Boston, Massachusetts
- RocheGroup Medical Director, Neurodegenerative Disorders2013 — 2017basel area, switzerland
- inVentiv Health CommercialVice President and General Manager, Neuroscience2012 — 2013Pharmanet-i3, Princeton, New Jersey
- ShireGeneral Manager, Emerging Business Unit2010 — 2012
- Shire PharmaceuticalsSenior Director, Clinical Development-Medical Affairs2008 — 2010
- Neuliance [Consulting and Clinical Practice]Founder2007 — 2008
- Comprehensive NeuroScience [now Comprehensive Clinical Development]Senior Vice President2006 — 2007
- Johnson & JohnsonExecutive Director, Global Medical Strategy Leader2005 — 2006
- Johnson & Johnson [Janssen]Senior Director, Medical Leader2001 — 2005
- Novartis PharmaceuticalsSenior Director, Medical Leader1998 — 2001
Skills & more
PsychiatryClinical DevelopmentPharmaceutical IndustryClinical TrialsNeurologyClinical ResearchNeuroscienceMedical AffairsBiotechnologyCROMarketing CommunicationsMarketing Strategy
+12 more
SchizophreniaADHDMajor Depressive DisorderBipolar DisorderMood DisordersSubstance Use DisordersCNS disordersPsychometricsOutcomes ResearchPatient OutcomesPatient Reported OutcomesPhase 2From Rob's professional profile.
Frequently asked questions
- Who is Rob Lasser?
- Chief Medical Officer at Noema Pharma
- Where does Rob Lasser work?
- Rob Lasser is Chief Medical Officer at Noema Pharma.
- Where did Rob Lasser go to school?
- Rob Lasser studied at National Institute of Mental Health (Geriatric Fellow, Geriatric Psychiatry, Neurodegerative Disorders); The Wharton School (MBA, Marketing, Management); Harvard Medical School (Residency, Psychiatry Residency Program).
Same school
Also attended National Institute of Mental Health1
Also attended Harvard Medical School331
Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 325 more
Also attended Boston University School of Medicine24
Parth DesaiPartner at Flare Capital PartnersBridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalMonica JainVenture Partner at Wavemaker Three-Sixty HealthJai ParekhDigital Health Advisor at Excelerate Health VenturesTom InselCo-Founder, Mindstrong, NIH at AIFSue SiegelHealth Moonshot Impact Board at StartUp Health
+ 18 more
Also attended Dartmouth College663
Scott SandellExecutive Chairman & Chief Investment Officer at NEAJames DetweilerVP of Investments at Felicis VenturesBen RobbinsInvestor at GV (Google Ventures)Mounisha AnumoluInvestor at GV (Google Ventures)Ren RileyAdvisor at Oak Investment PartnersJeffrey PaineFounding Partner at Golden Gate Ventures
+ 657 more
Shared employers
Also worked at Sage Therapeutics10
Jeffrey M. JonasPartner at Cure VenturesAlbert J. RobichaudPartner at Cure VenturesKiran ReddySenior Managing Director at Blackstone Life SciencesJamil BegPartner at 5AM VenturesAsha NayakInvestor at Johnson & Johnson Innovation – JJDCMatthew CalistriManaging Director at Bain Capital Life Sciences
+ 4 more
Also worked at Roche229
Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized Capital
+ 223 more
Also worked at Shire38
Sun AltbachSenior Scientific Advisor at BOLD LongevityJulie KimRepresentative Director – President and CEO at Takeda VenturesGabriele RicciChief Data & Technology Officer at Takeda VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesJeffrey M. JonasPartner at Cure VenturesSusan KilsbyAdvisor at Siddhi Capital
+ 32 more
